“For almost forty years, I’ve considered it an honor to be a doctor. I believe in our role as healers, and I believe in our role as truth-tellers. The truth we need to confront right now is that medicine and science are being politically perverted around the country in ways that destroy human lives.”
That’s Assistant Secretary for Health Admiral Rachel Levine, a USA Today Woman of the Year, and the Biden Administration’s most prominent transgender bureaucrat.
Speaking a few days ago at Texas Christian University, Levine declared: “Gender-affirming care is medical care. It is mental health care. It is suicide prevention care. It improves quality of life, and it saves lives. It is based on decades of study. It is a well-established medical practice.”
However, transgender care is far from being “well-established”, as Admiral Levine must surely know. In recent months, health authorities in one country after another in Europe have expressed their alarm, citing serious medical and psychological problems amongst people who have received “gender-affirming care”.
- In France, the National Academy of Medicine declared on February 25: “great medical caution must be taken in children and adolescents, given the vulnerability, particularly psychological, of this population and the many undesirable effects and even serious complications that can be caused by some of the therapies available”.
- In Sweden, the National Board of Health and Welfare issued new guidelines for gender-affirming care in February. It said, based on current knowledge: “the risks of puberty suppressing treatment with GnRH-analogues and gender-affirming hormonal treatment currently outweigh the possible benefits, and that the treatments should be offered only in exceptional cases.”
- In the United Kingdom, the National Institute for Health and Care Excellence (NICE) published two systematic reviews of puberty blockers in March 2021. It found that they “lead to little or no change in gender dysphoria, mental health, body image and psychosocial functioning. In the few studies that did report change, the results could be attributable to bias or chance, or were deemed unreliable.”
- In Finland, the Finnish Health Authority (PALKO/COHERE) reversed course in 2020. Its new guidance stated that “psychotherapy, rather than puberty blockers and cross-sex hormones, should be the first-line treatment for gender-dysphoric youth”.
Admiral Levine would benefit from viewing the last of four programs produced by the Swedish national broadcaster SVT about transgender medicine. Transbarnen (The Trans Children) examines the case of “Leo”, a ten-year-old girl who decided that she was really a boy. It is an appalling tale of abysmal medical care – at one of the world best hospitals, the Karolinska. The searing revelations from the SVT’s investigative reporters were one factor in the new guidelines in Sweden.
Here’s what Uppdrag Granskning (Mission Investigation) found.
At the age of 11, Leo embarked upon puberty blockers. The child and her mother were told that this was standard treatment and reversible.
“Leo was little when she wanted to become a he,’ her mother Natalie told the reporter, Carolina Jemsby. “I thought if this was his wish, I should agree with it. Everyone said Leo was brave to come out and I should be proud of him.”
The puberty blockers were meant to stop Leo from developing breasts, wider hips and menstruating. Their use is based on the so-called Dutch Protocol, developed in the Netherlands in 2011. But, as Jemsby points out, some experts have grave misgivings about this repeatedly-cited research. “The worry comes from the lack of long-term studies and that the Dutch study alone is not sufficient evidence. It has too few subjects, no control group and was done at only one clinic.”
Since a well-known side-effect of puberty blockers is a serious decrease in bone density, patients are supposed to be checked regularly. They should receive the powerful drugs for no longer than two years.
Leo was on the medication for four years and his bone density was never checked.
The effects were little short of catastrophic. Leo now suffers from severe osteoporosis, a weaking of bones which is normally seen in people in their 60s and 70s. It is almost irreversible. His mother says that he was in pain from skeletal damage; he was constantly depressed; and he attempted to commit suicide several times.
“But information about the potential risks and lack of evidence never reaches Leo and his family,” says Jemsby.
In fact, one of the most dismaying features of the Swedish journalists’ report is mismanagement in the medical bureaucracy. One group diagnosed children’s gender dysphoria; another administered the medications. They didn’t appear to communicate with each other. If this is one of the world’s best hospitals, what happens elsewhere?
Jemsby showed doctors incident reports not only on Leo, but on several children who had serious complications after embarking upon puberty blockers. The response? A lot of creased brows and finger-pointing and no answers. No one, it appears, was responsible.
“I think everyone involved in this case had good intentions,” Dr Ola Nilsson, a paediatric endocrinologist, says. “But now it’s time to take a step back and try to get really good data regarding what’s best – how best to diagnose and treat this group so we do more good than harm. Much more good than harm. Minimal harm and a lot of benefit is the goal of all healthcare.”
Unfortunately, the picture painted by the Swedish journalists is one of minimal benefit for children and a lot of buck-passing by doctors.
Leo’s back, shoulder and hips are constantly aching. His distraught mother says: “A 15-year-old shouldn’t have to deal with that. His bones shouldn’t look that way. A healthy skeleton that’s been destroyed by this medicine.”
Gender-affirming care “improves quality of life, and it saves lives,” says Admiral Levine. But it didn’t for Leo and for many other children. So many, that European healthcare regulators are slamming on the brakes for transgender care – while the Americans are turbo-charging it.
To cite Rachel Levine’s ill-chosen words, medicine and science are being “politically perverted”, but not by trans sceptics, but by the Biden Administration.
Michael Cook is the editor of MercatorNet. He lives in Sydney, Australia. More by Michael Cook
EDITORS NOTE: This MercatorNet column is republished with permission. ©All rights reserved.